Parental Support uses single-nucleotide polymorphism (SNP) technology with bioinformatics algorithms to create genetic information from small amounts of free-floating fetal DNA found in the mother’s blood.
GSN CEO Matthew Rabinowitz said the application of advanced statistics to non-invasive prenatal testing enables them to deliver information to expecting parents safely and early in the pregnancy.
"We are working for launching our non-invasive prenatal diagnostic test, based on the same technology, for Down syndrome and other genetic disorders," Rabinowitz said.
"We are initiating a large, prospective clinical trial, funded by the National Institutes of Health (NIH), with the maternal fetal medicine centers in the US to evualate the efficacy."
